HomeCompareDIUXF vs MRK

DIUXF vs MRK: Dividend Comparison 2026

DIUXF yields 119.76% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DIUXF wins by $8.41M in total portfolio value
10 years
DIUXF
DIUXF
● Live price
119.76%
Share price
$1.67
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.47M
Annual income
$3,204,971.89
Full DIUXF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — DIUXF vs MRK

📍 DIUXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDIUXFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DIUXF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DIUXF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DIUXF
Annual income on $10K today (after 15% tax)
$10,179.64/yr
After 10yr DRIP, annual income (after tax)
$2,724,226.11/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, DIUXF beats the other by $2,715,897.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DIUXF + MRK for your $10,000?

DIUXF: 50%MRK: 50%
100% MRK50/50100% DIUXF
Portfolio after 10yr
$4.26M
Annual income
$1,607,385.02/yr
Blended yield
37.70%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

DIUXF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
11.5
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DIUXF buys
0
MRK buys
0
No recent congressional trades found for DIUXF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDIUXFMRK
Forward yield119.76%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$8.47M$56.8K
Annual income after 10y$3,204,971.89$9,798.13
Total dividends collected$7.70M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: DIUXF vs MRK ($10,000, DRIP)

YearDIUXF PortfolioDIUXF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$22,676$11,976.05$11,206$366.19+$11.5KDIUXF
2$49,644$25,380.32$12,650$502.35+$37.0KDIUXF
3$105,048$51,929.01$14,407$694.19+$90.6KDIUXF
4$215,096$102,694.93$16,585$967.82+$198.5KDIUXF
5$426,675$196,521.84$19,342$1,363.89+$407.3KDIUXF
6$820,869$364,327.05$22,913$1,947.19+$798.0KDIUXF
7$1,533,395$655,065.37$27,662$2,823.89+$1.51MDIUXF
8$2,784,351$1,143,618.41$34,159$4,173.35+$2.75MDIUXF
9$4,919,995$1,940,739.75$43,337$6,308.80+$4.88MDIUXF
10$8,469,367$3,204,971.89$56,776$9,798.13+$8.41MDIUXF

DIUXF vs MRK: Complete Analysis 2026

DIUXFStock

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX patient journey that enables pharma customers to complete a longitudinal analysis of biomarker testing journeys of individual patients, which identifies opportunities for earlier testing and treatment; DXRX lab benchmarking that enables laboratories to gain competitive edge and compare key criteria to others in the industry providing metrics, such as disease, testing and methodology, market share, turnaround time, and laboratory leadership in these areas; DXRX test reimbursement, which enables pharma customers to engage with laboratories to fund the introduction of novel companion diagnostics, as well as reducing the lag time in test adoption; and DXRX test signal that delivers a real-time alert of a testing event, which allows pharma customers to identify therapeutically actionable patients in the previous weeks. In addition, it offers diagnostic landscape, planning, implementation, and tracking services; and consulting services for precision medicine diagnostics. Further, the company provides test standardization, test quality assessment, test report optimization, laboratory tech support, test access and reimbursement, laboratory training, and educational resources services. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.

Full DIUXF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this DIUXF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DIUXF vs SCHDDIUXF vs JEPIDIUXF vs ODIUXF vs KODIUXF vs MAINDIUXF vs JNJDIUXF vs ABBVDIUXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.